Healthcare Roundup – House gears up for historic vote on cannabis legalization, Moderna boosts COVID-19 vaccine deal with Israel to 6M doses Life Science
Technology Roundup – Completely driverless cars are on the streets in China, Global semiconductor sales in October increased Y/Y Technology
Technology Roundup – Trump administration confirms SMIC, CNOOC added to blacklist, Amazon and Yeti team up to sue e-commerce counterfeiters Technology
Healthcare Roundup – U.S. could immunize one-third of population, JD Health raises $3.5B in Hong Kong IPO Life Science
Healthcare Roundup – U.K. becomes first country to authorize Pfizer-BioNTech vaccine for emergency use; Feds buy another 650K doses of Lilly COVID-19 med bamlanivimab Life Science
Technology Roundup － Nokia says 5G is 90% more energy efficient, Micron treks higher with Needham supporting the bull case Technology
Healthcare Roundup – Moderna shares reverse big early gains in bout of profit-taking, FDA OKs emergency use of Roche test Life Science
Technology Roundup – Facebook-backed Libra currency group renames itself Diem, Salesforce acquiring Slack Technology
Healthcare Roundup – Moderna’s COVID vaccine scheduled for FDA review, BioNTech -2% post-market following BofA downgrade Life Science
Technology Roundup – Facebook seals deal for customer-service start-up Kustomer, Amazon Web Services installing Macs Technology
Healthcare Roundup – Sorrento Therapeutics rallies, Exelixis/Takeda’s Cabometyx Ok’d in Japan for liver cancer Life Science
Technology Roundup – Zoom shares gain ahead of Monday’s Q3 report, Amazon’s historic hiring spree added an average of 1,400 workers per day for 10 months Technology
Healthcare Roundup – CEO says AstraZeneca likely to run new global vaccine test, Equillium nixes plan to start late-stage trials of COVID-19 treatment Life Science
Technology Roundup – Crypto selloff sees Bitcoin shed almost $3K after nearing record highs, Ant Group explores capital injections amid fintech crackdown Technology
Healthcare Roundup – AstraZeneca skids another 2% as confusion remains over vaccine, Adial Pharmaceuticals inks stock purchase agreement with Keystone Capital Life Science
